In an interview on CNBC’s Mad Money, Steve MacMillan said Hologic’s core business is growing at a double digit rate. “This year, our stock is still dealing with a Covid hangover,” he noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HOLX: